Clinical trial
Rationale and Design of a Prospective, Open Label, Randomized, Multicentric Clinical Trial: Drug Coated Balloon for Side Branch Treatment vs. Conventional Approach in True Bifurcation Coronary Disease: PRO-DAVID
NCT04403048 is registered in ClinicalTrials.gov with Clinical Hospital Center Rijeka as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rationale and Design of a Prospective, Open Label, Randomized, Multicentric Clinical Trial: Drug Coated Balloon for Side Branch Treatment vs. Conventional Approach in True Bifurcation Coronary Disease: PRO-DAVID
- Lead sponsor
- Clinical Hospital Center Rijeka
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2020
- Completion date
- April 30, 2024
- Enrollment
- 800 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, ischemic heart disease, nstemi - non-st segment elevation mi, stable angina, unstable angina